Related Experiment Video
Updated: May 10, 2026
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Non-cystic fibrosis bronchiectasis
M J McDonnell1, C Ward, J L Lordan
1Department of Respiratory Medicine, Galway University Hospitals, Newcastle Road, Galway, Ireland. melissajanefriel@gmail.com
Summary
Bronchiectasis is a chronic lung disease causing airway damage, leading to persistent cough and infections. Understanding its diverse causes and improving management are crucial for patient well-being.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Bronchiectasis is a chronic respiratory condition characterized by irreversible airway dilation.
- It involves a persistent cycle of infection and inflammation, leading to significant patient morbidity.
- The condition presents with diverse phenotypes, impacting quality of life and healthcare costs.
Purpose of the Study:
- To provide a comprehensive review of current knowledge on bronchiectasis.
- To elucidate the pathophysiology and diverse etiologies of the disease.
- To discuss current and potential management strategies for bronchiectasis.
Main Methods:
- Literature review of existing research on bronchiectasis.
- Synthesis of information on disease mechanisms, causes, and treatments.
- Analysis of the impact of bronchiectasis on patients and healthcare systems.
Main Results:
- Bronchiectasis results from a complex interplay of factors leading to airway damage.
- Persistent infection and inflammation are key features, driving disease progression.
- Current management focuses on symptom control, infection prevention, and airway clearance.
Conclusions:
- Further research is essential to better understand bronchiectasis development and progression.
- Improved understanding can lead to enhanced diagnostic and therapeutic approaches.
- Addressing the phenotypic diversity is key to optimizing patient outcomes.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...